Talphera, Inc., a leading innovator in the biotechnology sector, is headquartered in the United States and operates across key regions globally. Founded in 2015, the company has rapidly established itself in the fields of drug development and advanced therapeutics, focusing on precision medicine solutions that cater to unmet medical needs. Talphera's core offerings include cutting-edge biopharmaceuticals and diagnostic tools, distinguished by their commitment to enhancing patient outcomes through tailored therapies. The company has achieved significant milestones, including successful clinical trials and partnerships with major healthcare institutions, solidifying its position as a trusted name in the industry. With a dedication to research and development, Talphera continues to push the boundaries of innovation, making a meaningful impact in the healthcare landscape.
How does Talphera, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Talphera, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Talphera, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Talphera may be in the early stages of developing its climate commitments or may not yet have established formal targets for emissions reduction. As the company does not inherit emissions data from a parent organisation, it operates independently in terms of climate reporting. Without specific emissions figures or reduction initiatives, it is unclear how Talphera, Inc. aligns with industry standards for carbon management and sustainability.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Talphera, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
